Utilization of the ambulatory dermatology encounter among patients with hidradenitis suppurativa (HS) is low in the US, according to a recent study. Furthermore, factors other than insurance status influenced this level of utilization. Researchers conducted a retrospective cohort analysis in an adult population sample of 42,030 patients with HS with either private or public health insurance who were identified by a validated scheme using SNOMED-CT terminology. The primary outcome was a dichotomous variable defined as having at least 1 ambulatory encounter with a dermatologist over a 3-year period. They found:
- Overall, 21.8% of the HS patients had at least 1 ambulatory encounter with a dermatologist.
- This proportion did not significantly vary between patients with private insurance (22%), Medicaid (21.6%), and Medicare (21.7%).
Garg A, Lavian J, Strunk A. Low utilization of the dermatology ambulatory encounter among patients with hidradenitis suppurativa: A population-based retrospective cohort analysis in the USA. [Published online ahead of print September 28, 2017]. Dermatology (Karger). doi:10.1159/000480379.
This Week's Must Reads
Must Reads in Rare Diseases
Risk Prediction of In-Hospital Mortality for SJS/TEN, JAMA Dermatol; ePub 2019 Mar 6; Noe, et al